Inventor
CHOI HYEONG WOOK
US35 patents
⚠️ This page may combine multiple inventors who share the name “CHOI HYEONG WOOK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EISAI R&D MAN CO LTD
21 patentsUS9783549B2Oct 10, 2017
Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B
EISAI R&D MAN CO LTD16 citations92
US10611773B2Apr 7, 2020
Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B
EISAI R&D MAN CO LTD5 citations84
US10308661B2Jun 4, 2019
Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
EISAI R&D MAN CO LTD9 citations84
US10221189B2Mar 5, 2019
Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B
EISAI R&D MAN CO LTD10 citations84
US10246480B2Apr 2, 2019
Compounds for the treatment of cancer
EISAI R&D MAN CO LTD5 citations83
US10934307B2Mar 2, 2021
Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B
EISAI R&D MAN CO LTD2 citations73
US10836784B2Nov 17, 2020
Substituted phosphorodiamidate morpholino oligomers
EISAI R&D MAN CO LTD2 citations70
US10457698B2Oct 29, 2019
Chiral reagents for preparation of substituted phosphorodiamidate morpholino oligomers
EISAI R&D MAN CO LTD4 citations70
US11643418B2May 9, 2023
Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B
EISAI R&D MAN CO LTD0 citations62
US10913749B2Feb 9, 2021
Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
EISAI R&D MAN CO LTD0 citations62
US12251394B2Mar 18, 2025
Methods for the treatment of bladder cancer
EISAI R&D MAN CO LTD0 citations61
US11339188B2May 24, 2022
Compounds for the treatment of cancer
EISAI R&D MAN CO LTD0 citations61
US11434246B2Sep 6, 2022
EP4 antagonists
EISAI R&D MAN CO LTD0 citations60
US10941148B2Mar 9, 2021
EP4 antagonists
EISAI R&D MAN CO LTD0 citations60
US11542269B2Jan 3, 2023
Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
EISAI R&D MAN CO LTD0 citations52
US11136335B2Oct 5, 2021
Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
EISAI R&D MAN CO LTD0 citations52
US10793581B2Oct 6, 2020
Stereochemically defined polypropionates and methods for making and using the same
EISAI R&D MAN CO LTD0 citations51
US10618930B2Apr 14, 2020
Compounds for the treatment of cancer
EISAI R&D MAN CO LTD0 citations51
US10407439B2Sep 10, 2019
Stereochemically defined polypropionates and methods for making and using the same
EISAI R&D MAN CO LTD0 citations51
US10160768B2Dec 25, 2018
Stereochemically defined polypropionates and methods for making and using the same
EISAI R&D MAN CO LTD0 citations51
US10316040B2Jun 11, 2019
EP4 antagonists
EISAI R&D MAN CO LTD0 citations49
EPIZYME INC
8 patentsUS9394283B2Jul 19, 2016
Salt form of a human histone methyltransferase EZH2 inhibitor
EPIZYME INC27 citations96
US9872862B2Jan 23, 2018
Salt form of a human histone methyltransferase EZH2 inhibitor
EPIZYME INC14 citations91
US11491163B2Nov 8, 2022
Salt form of a human histone methyltransferase EZH2 inhibitor
EPIZYME INC6 citations85
US10821113B2Nov 3, 2020
Salt form of a human histone methyltransferase EZH2 inhibitor
EPIZYME INC6 citations83
US10710987B2Jul 14, 2020
Hydrochloride salt form for EZH2 inhibition
EPIZYME INC8 citations83
US10245269B2Apr 2, 2019
Salt form of a human histone methyltransferase EZH2 inhibitor
EPIZYME INC8 citations83
US10040782B2Aug 7, 2018
Hydrochloride salt form for EZH2 inhibition
EPIZYME INC12 citations83
US12251386B2Mar 18, 2025
Salt form of a human histone methyltransferase EZH2 inhibitor
EPIZYME INC0 citations62
OTSUKA PHARMA CO LTD
3 patentsUS9834576B2Dec 5, 2017
Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridines
OTSUKA PHARMA CO LTD7 citations82
US10526362B2Jan 7, 2020
Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridines
OTSUKA PHARMA CO LTD1 citations71
US11028119B2Jun 8, 2021
Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridines
OTSUKA PHARMA CO LTD0 citations60
LG LIFE SCIENCES LTD
3 patentsUS8044080B2Oct 25, 2011
Isoxazoline derivative and novel process for its preparation
LG LIFE SCIENCES LTD3 citations60
US7906676B2Mar 15, 2011
Process for preparing 3-amino-5-fluoro-4-dialkoxypentanoic acid ester
LG LIFE SCIENCES LTD0 citations51
US7557133B2Jul 7, 2009
Caspase inhibitors containing isoxazoline ring
LG LIFE SCIENCES LTD1 citations47